incretin mimetic agents glp 1 receptor agonists GLP-1 and Research to Treat Overeating and Substance Use Disorders The protective role of GLP-1

Combined with the theory of GIP being an obesogenic hormone (53), these prior findings have highlighted the potential of GIP receptor antagonism, and today the development of GIP receptor antagonists has also emerged as an attractive therapeutic approach for addressing obesity and cardiovascular diseases (54, 55)

Disclosure The statements, opinions, and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s)

Phentermine addresses appetite through central nervous system stimulation

Currently available drugs in this class, like exenatide and liraglutide have revolutionized diabetes treatment

Prism 10 was used for data analysis